Composition Containing Ginsenoside F1 Or Compound K For Skin External Application
First Claim
Patent Images
1. An inhibitor of the biosynthesis of gelatinase comprising one or more of ginsenoside F1 and compound K as an active ingredient.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to an inhibitor for the biosynthesis of gelatinase comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) or compound K (20-0-β-D-glucopyranosyl-20(S)-protopanaxadiol), which is a chief metabolite of ginseng saponin, as an active ingredient; and a cosmetic/medical composition for the prevention of skin-aging comprising the same which is superior in inhibiting the decomposition of epidermal-dermal junction and also in accelerating the generation thereof.
-
Citations
5 Claims
- 1. An inhibitor of the biosynthesis of gelatinase comprising one or more of ginsenoside F1 and compound K as an active ingredient.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeAmorepacific Corporation
-
Original AssigneeAmorepacific Corporation
-
InventorsKim, Su-Jong, Kim, Su-Nam, Lee, So-Hee, Choi, Gyu-Ho, Lee, Byeong-Gon, Kang, Byung Young, Kim, Han-Kon
-
Application NumberUS10/586,973Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current514/26CPC Class CodesA61K 31/70 Carbohydrates; Sugars; Deri...A61K 8/63 Steroids; Derivatives thereofA61P 17/00 Drugs for dermatological di...A61P 43/00 Drugs for specific purposes...A61Q 19/08 Anti-ageing preparations
